Hypera 2Q26 net income climbs 15% to R$490 million; net revenue rises 8.5% to R$2.34 billion

Reuters2026/08/06 21:54

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Hypera posted 2Q26 net revenue of R$ 2.34 billion, up 8.5% from 2Q25; net income from continuing operations rose 15% to R$ 490 million.
Operating cash flow jumped 85% to R$ 819.2 million, equal to 108.5% of EBITDA from continuing operations.
Gross margin widened 1.7 percentage points to 61.8%; EBITDA from continuing operations increased 4.1% to R$ 754.9 million.
Net debt fell to R$ 5.9 billion, down R$ 397.6 million from end-1Q26, reflecting stronger free cash flow of R$ 637.8 million.
Hypera announced an Astellas partnership for fezolinetant menopause treatments, while ANVISA approved Semavy, marking its entry into Brazil’s GLP-1 analog market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hypera SA published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Hypera 2Q26 net income climbs 15% to R$490 million; net revenue rises 8.5% to R$2.34 billion

You may also like

Crypto prices